nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCB11—Ethinyl Estradiol—osteoporosis	0.11	0.192	CbGbCtD
Vinblastine—ABCC1—Zoledronate—osteoporosis	0.103	0.18	CbGbCtD
Vinblastine—ABCC2—Ethinyl Estradiol—osteoporosis	0.0579	0.101	CbGbCtD
Vinblastine—ABCC1—Conjugated Estrogens—osteoporosis	0.0574	0.1	CbGbCtD
Vinblastine—SLC22A2—Estradiol—osteoporosis	0.0457	0.0798	CbGbCtD
Vinblastine—ABCC2—Conjugated Estrogens—osteoporosis	0.0425	0.0742	CbGbCtD
Vinblastine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0189	0.033	CbGbCtD
Vinblastine—CYP3A4—Estropipate—osteoporosis	0.0176	0.0306	CbGbCtD
Vinblastine—CYP3A4—Calcitriol—osteoporosis	0.0176	0.0306	CbGbCtD
Vinblastine—CYP2D6—Cholecalciferol—osteoporosis	0.0142	0.0248	CbGbCtD
Vinblastine—CYP3A4—Ergocalciferol—osteoporosis	0.014	0.0245	CbGbCtD
Vinblastine—ABCB1—Conjugated Estrogens—osteoporosis	0.0139	0.0242	CbGbCtD
Vinblastine—ABCB1—Estradiol—osteoporosis	0.0122	0.0212	CbGbCtD
Vinblastine—CYP3A4—Raloxifene—osteoporosis	0.0117	0.0204	CbGbCtD
Vinblastine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0113	0.0197	CbGbCtD
Vinblastine—CYP3A4—Cholecalciferol—osteoporosis	0.00904	0.0158	CbGbCtD
Vinblastine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0083	0.0145	CbGbCtD
Vinblastine—CYP3A4—Estradiol—osteoporosis	0.00729	0.0127	CbGbCtD
Vinblastine—JUN—periosteum—osteoporosis	0.00695	0.28	CbGeAlD
Vinblastine—TUBG1—Fulvestrant—Estradiol—osteoporosis	0.00296	0.728	CbGdCrCtD
Vinblastine—TUBD1—bone marrow—osteoporosis	0.00168	0.0675	CbGeAlD
Vinblastine—TUBG1—uterus—osteoporosis	0.00166	0.0667	CbGeAlD
Vinblastine—TUBE1—bone marrow—osteoporosis	0.00157	0.0633	CbGeAlD
Vinblastine—TUBG1—bone marrow—osteoporosis	0.00141	0.0566	CbGeAlD
Vinblastine—TUBB1—bone marrow—osteoporosis	0.00112	0.045	CbGeAlD
Vinblastine—TUBA1A—uterus—osteoporosis	0.00096	0.0386	CbGeAlD
Vinblastine—JUN—uterus—osteoporosis	0.00095	0.0383	CbGeAlD
Vinblastine—TUBB4A—uterus—osteoporosis	0.00082	0.033	CbGeAlD
Vinblastine—TUBA1A—bone marrow—osteoporosis	0.000814	0.0328	CbGeAlD
Vinblastine—JUN—bone marrow—osteoporosis	0.000807	0.0325	CbGeAlD
Vinblastine—TUBB—uterus—osteoporosis	0.00075	0.0302	CbGeAlD
Vinblastine—TUBB2A—uterus—osteoporosis	0.000746	0.03	CbGeAlD
Vinblastine—TUBB6—uterus—osteoporosis	0.000736	0.0296	CbGeAlD
Vinblastine—Hypersensitivity—Calcium Acetate—osteoporosis	0.000711	0.00411	CcSEcCtD
Vinblastine—Leukopenia—Etidronic acid—osteoporosis	0.000695	0.00402	CcSEcCtD
Vinblastine—Depression—Ethinyl Estradiol—osteoporosis	0.000694	0.00402	CcSEcCtD
Vinblastine—Asthenia—Calcium Acetate—osteoporosis	0.000692	0.00401	CcSEcCtD
Vinblastine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.000686	0.00397	CcSEcCtD
Vinblastine—Phlebitis—Estradiol—osteoporosis	0.000684	0.00396	CcSEcCtD
Vinblastine—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.000683	0.00395	CcSEcCtD
Vinblastine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.000683	0.00395	CcSEcCtD
Vinblastine—Alopecia—Estropipate—osteoporosis	0.000682	0.00394	CcSEcCtD
Vinblastine—Depression—Risedronate—osteoporosis	0.000677	0.00392	CcSEcCtD
Vinblastine—Alopecia—Alendronate—osteoporosis	0.000671	0.00388	CcSEcCtD
Vinblastine—TUBB6—Fulvestrant—Estradiol—osteoporosis	0.000667	0.164	CbGdCrCtD
Vinblastine—Diarrhoea—Calcium Acetate—osteoporosis	0.00066	0.00382	CcSEcCtD
Vinblastine—Deafness—Estradiol—osteoporosis	0.000659	0.00381	CcSEcCtD
Vinblastine—Alopecia—Ibandronate—osteoporosis	0.000654	0.00378	CcSEcCtD
Vinblastine—Discomfort—Etidronic acid—osteoporosis	0.000653	0.00378	CcSEcCtD
Vinblastine—TUBB4B—uterus—osteoporosis	0.00064	0.0257	CbGeAlD
Vinblastine—Dizziness—Calcium Acetate—osteoporosis	0.000638	0.00369	CcSEcCtD
Vinblastine—TUBB—bone marrow—osteoporosis	0.000637	0.0256	CbGeAlD
Vinblastine—TUBB2A—bone marrow—osteoporosis	0.000633	0.0255	CbGeAlD
Vinblastine—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000628	0.00364	CcSEcCtD
Vinblastine—Pancytopenia—Zoledronate—osteoporosis	0.000628	0.00363	CcSEcCtD
Vinblastine—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000625	0.00362	CcSEcCtD
Vinblastine—TUBB6—bone marrow—osteoporosis	0.000624	0.0251	CbGeAlD
Vinblastine—Hypoaesthesia—Ethinyl Estradiol—osteoporosis	0.000622	0.0036	CcSEcCtD
Vinblastine—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.00062	0.00359	CcSEcCtD
Vinblastine—Ill-defined disorder—Alendronate—osteoporosis	0.000614	0.00355	CcSEcCtD
Vinblastine—Vomiting—Calcium Acetate—osteoporosis	0.000613	0.00355	CcSEcCtD
Vinblastine—Haemoglobin—Risedronate—osteoporosis	0.000613	0.00355	CcSEcCtD
Vinblastine—Asthenia—Ergocalciferol—osteoporosis	0.000611	0.00354	CcSEcCtD
Vinblastine—Anaemia—Alendronate—osteoporosis	0.000611	0.00354	CcSEcCtD
Vinblastine—Haemorrhage—Risedronate—osteoporosis	0.000609	0.00353	CcSEcCtD
Vinblastine—Pharyngitis—Risedronate—osteoporosis	0.000605	0.0035	CcSEcCtD
Vinblastine—Vertigo—Estropipate—osteoporosis	0.000603	0.00349	CcSEcCtD
Vinblastine—Agranulocytosis—Pamidronate—osteoporosis	0.000602	0.00349	CcSEcCtD
Vinblastine—Cerebrovascular accident—Estradiol—osteoporosis	0.000602	0.00348	CcSEcCtD
Vinblastine—Ill-defined disorder—Ibandronate—osteoporosis	0.000597	0.00346	CcSEcCtD
Vinblastine—Malaise—Alendronate—osteoporosis	0.000596	0.00345	CcSEcCtD
Vinblastine—Anaemia—Ibandronate—osteoporosis	0.000595	0.00344	CcSEcCtD
Vinblastine—Vertigo—Alendronate—osteoporosis	0.000594	0.00344	CcSEcCtD
Vinblastine—Depression—Zoledronate—osteoporosis	0.000588	0.0034	CcSEcCtD
Vinblastine—Vertigo—Raloxifene—osteoporosis	0.000584	0.00338	CcSEcCtD
Vinblastine—Haemoglobin—Pamidronate—osteoporosis	0.000582	0.00337	CcSEcCtD
Vinblastine—Malaise—Ibandronate—osteoporosis	0.000581	0.00336	CcSEcCtD
Vinblastine—Haemorrhage—Pamidronate—osteoporosis	0.000579	0.00335	CcSEcCtD
Vinblastine—Vertigo—Ibandronate—osteoporosis	0.000578	0.00335	CcSEcCtD
Vinblastine—Nausea—Calcium Acetate—osteoporosis	0.000573	0.00332	CcSEcCtD
Vinblastine—Paraesthesia—Etidronic acid—osteoporosis	0.000569	0.00329	CcSEcCtD
Vinblastine—Depression—Conjugated Estrogens—osteoporosis	0.000566	0.00328	CcSEcCtD
Vinblastine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00056	0.00324	CcSEcCtD
Vinblastine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000556	0.00322	CcSEcCtD
Vinblastine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.000556	0.00322	CcSEcCtD
Vinblastine—Discomfort—Alendronate—osteoporosis	0.000556	0.00322	CcSEcCtD
Vinblastine—Hypertension—Ibandronate—osteoporosis	0.000556	0.00322	CcSEcCtD
Vinblastine—Alopecia—Ethinyl Estradiol—osteoporosis	0.000552	0.0032	CcSEcCtD
Vinblastine—Agranulocytosis—Zoledronate—osteoporosis	0.00055	0.00318	CcSEcCtD
Vinblastine—Convulsion—Calcitriol—osteoporosis	0.000546	0.00316	CcSEcCtD
Vinblastine—Hypertension—Calcitriol—osteoporosis	0.000544	0.00315	CcSEcCtD
Vinblastine—TUBB4B—bone marrow—osteoporosis	0.000543	0.0219	CbGeAlD
Vinblastine—Constipation—Etidronic acid—osteoporosis	0.000542	0.00313	CcSEcCtD
Vinblastine—Discomfort—Ibandronate—osteoporosis	0.000542	0.00313	CcSEcCtD
Vinblastine—Discomfort—Calcitriol—osteoporosis	0.00053	0.00307	CcSEcCtD
Vinblastine—Hypoaesthesia—Zoledronate—osteoporosis	0.000527	0.00305	CcSEcCtD
Vinblastine—Feeling abnormal—Etidronic acid—osteoporosis	0.000522	0.00302	CcSEcCtD
Vinblastine—Thrombocytopenia—Raloxifene—osteoporosis	0.00052	0.00301	CcSEcCtD
Vinblastine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000518	0.003	CcSEcCtD
Vinblastine—Alopecia—Pamidronate—osteoporosis	0.000512	0.00296	CcSEcCtD
Vinblastine—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000507	0.00293	CcSEcCtD
Vinblastine—Nausea—Ergocalciferol—osteoporosis	0.000506	0.00293	CcSEcCtD
Vinblastine—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000506	0.00293	CcSEcCtD
Vinblastine—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000505	0.00292	CcSEcCtD
Vinblastine—Abdominal pain—Etidronic acid—osteoporosis	0.000501	0.0029	CcSEcCtD
Vinblastine—Paraesthesia—Estropipate—osteoporosis	0.000492	0.00285	CcSEcCtD
Vinblastine—Malaise—Ethinyl Estradiol—osteoporosis	0.000491	0.00284	CcSEcCtD
Vinblastine—Anaemia—Risedronate—osteoporosis	0.00049	0.00284	CcSEcCtD
Vinblastine—Anorexia—Calcitriol—osteoporosis	0.00049	0.00284	CcSEcCtD
Vinblastine—Vertigo—Risedronate—osteoporosis	0.000477	0.00276	CcSEcCtD
Vinblastine—Paraesthesia—Ibandronate—osteoporosis	0.000472	0.00273	CcSEcCtD
Vinblastine—Pain—Estropipate—osteoporosis	0.000469	0.00271	CcSEcCtD
Vinblastine—Constipation—Estropipate—osteoporosis	0.000469	0.00271	CcSEcCtD
Vinblastine—Ill-defined disorder—Pamidronate—osteoporosis	0.000468	0.00271	CcSEcCtD
Vinblastine—Alopecia—Zoledronate—osteoporosis	0.000468	0.00271	CcSEcCtD
Vinblastine—Hypersensitivity—Etidronic acid—osteoporosis	0.000467	0.0027	CcSEcCtD
Vinblastine—Anaemia—Pamidronate—osteoporosis	0.000466	0.0027	CcSEcCtD
Vinblastine—Constipation—Alendronate—osteoporosis	0.000462	0.00267	CcSEcCtD
Vinblastine—Pain—Alendronate—osteoporosis	0.000462	0.00267	CcSEcCtD
Vinblastine—Hypertension—Risedronate—osteoporosis	0.000458	0.00265	CcSEcCtD
Vinblastine—Discomfort—Ethinyl Estradiol—osteoporosis	0.000458	0.00265	CcSEcCtD
Vinblastine—Decreased appetite—Ibandronate—osteoporosis	0.000457	0.00264	CcSEcCtD
Vinblastine—ABCC1—uterus—osteoporosis	0.000456	0.0183	CbGeAlD
Vinblastine—Malaise—Pamidronate—osteoporosis	0.000455	0.00263	CcSEcCtD
Vinblastine—Pain—Raloxifene—osteoporosis	0.000454	0.00263	CcSEcCtD
Vinblastine—Depression—Estradiol—osteoporosis	0.000453	0.00262	CcSEcCtD
Vinblastine—Leukopenia—Pamidronate—osteoporosis	0.000451	0.00261	CcSEcCtD
Vinblastine—Alopecia—Conjugated Estrogens—osteoporosis	0.00045	0.00261	CcSEcCtD
Vinblastine—Pain—Ibandronate—osteoporosis	0.000449	0.0026	CcSEcCtD
Vinblastine—Constipation—Ibandronate—osteoporosis	0.000449	0.0026	CcSEcCtD
Vinblastine—Gastrointestinal pain—Estropipate—osteoporosis	0.000448	0.00259	CcSEcCtD
Vinblastine—Acute coronary syndrome—Estradiol—osteoporosis	0.000448	0.00259	CcSEcCtD
Vinblastine—Decreased appetite—Calcitriol—osteoporosis	0.000447	0.00259	CcSEcCtD
Vinblastine—Neuropathy peripheral—Estradiol—osteoporosis	0.000445	0.00258	CcSEcCtD
Vinblastine—Myocardial infarction—Estradiol—osteoporosis	0.000445	0.00258	CcSEcCtD
Vinblastine—Feeling abnormal—Alendronate—osteoporosis	0.000445	0.00257	CcSEcCtD
Vinblastine—Gastrointestinal pain—Alendronate—osteoporosis	0.000441	0.00255	CcSEcCtD
Vinblastine—TUBB6—Levorphanol—Estradiol—osteoporosis	0.000441	0.108	CbGdCrCtD
Vinblastine—Pain—Calcitriol—osteoporosis	0.00044	0.00255	CcSEcCtD
Vinblastine—Constipation—Calcitriol—osteoporosis	0.00044	0.00255	CcSEcCtD
Vinblastine—Convulsion—Pamidronate—osteoporosis	0.000437	0.00253	CcSEcCtD
Vinblastine—Hypertension—Pamidronate—osteoporosis	0.000435	0.00252	CcSEcCtD
Vinblastine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000434	0.00251	CcSEcCtD
Vinblastine—Diarrhoea—Etidronic acid—osteoporosis	0.000433	0.00251	CcSEcCtD
Vinblastine—Abdominal pain—Estropipate—osteoporosis	0.000433	0.00251	CcSEcCtD
Vinblastine—Feeling abnormal—Ibandronate—osteoporosis	0.000433	0.00251	CcSEcCtD
Vinblastine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00043	0.00249	CcSEcCtD
Vinblastine—Ill-defined disorder—Zoledronate—osteoporosis	0.000427	0.00247	CcSEcCtD
Vinblastine—Abdominal pain—Alendronate—osteoporosis	0.000427	0.00247	CcSEcCtD
Vinblastine—Anaemia—Zoledronate—osteoporosis	0.000426	0.00246	CcSEcCtD
Vinblastine—Discomfort—Pamidronate—osteoporosis	0.000424	0.00246	CcSEcCtD
Vinblastine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000421	0.00243	CcSEcCtD
Vinblastine—Abdominal pain—Raloxifene—osteoporosis	0.00042	0.00243	CcSEcCtD
Vinblastine—Malaise—Zoledronate—osteoporosis	0.000415	0.0024	CcSEcCtD
Vinblastine—Abdominal pain—Ibandronate—osteoporosis	0.000415	0.0024	CcSEcCtD
Vinblastine—Vertigo—Zoledronate—osteoporosis	0.000414	0.0024	CcSEcCtD
Vinblastine—Leukopenia—Zoledronate—osteoporosis	0.000412	0.00239	CcSEcCtD
Vinblastine—Haemoglobin—Estradiol—osteoporosis	0.00041	0.00237	CcSEcCtD
Vinblastine—Haemorrhage—Estradiol—osteoporosis	0.000408	0.00236	CcSEcCtD
Vinblastine—Abdominal pain—Calcitriol—osteoporosis	0.000407	0.00235	CcSEcCtD
Vinblastine—Hypoaesthesia—Estradiol—osteoporosis	0.000406	0.00235	CcSEcCtD
Vinblastine—Pharyngitis—Estradiol—osteoporosis	0.000405	0.00234	CcSEcCtD
Vinblastine—Hypersensitivity—Estropipate—osteoporosis	0.000404	0.00234	CcSEcCtD
Vinblastine—Thrombocytopenia—Pamidronate—osteoporosis	0.000403	0.00233	CcSEcCtD
Vinblastine—Vomiting—Etidronic acid—osteoporosis	0.000403	0.00233	CcSEcCtD
Vinblastine—Convulsion—Zoledronate—osteoporosis	0.000399	0.00231	CcSEcCtD
Vinblastine—Vertigo—Conjugated Estrogens—osteoporosis	0.000399	0.00231	CcSEcCtD
Vinblastine—Hypertension—Zoledronate—osteoporosis	0.000398	0.0023	CcSEcCtD
Vinblastine—Hypersensitivity—Alendronate—osteoporosis	0.000398	0.0023	CcSEcCtD
Vinblastine—Headache—Etidronic acid—osteoporosis	0.000397	0.0023	CcSEcCtD
Vinblastine—Asthenia—Estropipate—osteoporosis	0.000393	0.00228	CcSEcCtD
Vinblastine—Anorexia—Pamidronate—osteoporosis	0.000392	0.00227	CcSEcCtD
Vinblastine—Paraesthesia—Risedronate—osteoporosis	0.000389	0.00225	CcSEcCtD
Vinblastine—Discomfort—Zoledronate—osteoporosis	0.000388	0.00224	CcSEcCtD
Vinblastine—Asthenia—Alendronate—osteoporosis	0.000387	0.00224	CcSEcCtD
Vinblastine—Hypersensitivity—Ibandronate—osteoporosis	0.000387	0.00224	CcSEcCtD
Vinblastine—Convulsion—Conjugated Estrogens—osteoporosis	0.000384	0.00222	CcSEcCtD
Vinblastine—Constipation—Ethinyl Estradiol—osteoporosis	0.00038	0.0022	CcSEcCtD
Vinblastine—Hypersensitivity—Calcitriol—osteoporosis	0.000379	0.00219	CcSEcCtD
Vinblastine—Asthenia—Ibandronate—osteoporosis	0.000377	0.00218	CcSEcCtD
Vinblastine—Nausea—Etidronic acid—osteoporosis	0.000376	0.00218	CcSEcCtD
Vinblastine—Diarrhoea—Estropipate—osteoporosis	0.000375	0.00217	CcSEcCtD
Vinblastine—Pain—Risedronate—osteoporosis	0.00037	0.00214	CcSEcCtD
Vinblastine—Constipation—Risedronate—osteoporosis	0.00037	0.00214	CcSEcCtD
Vinblastine—Paraesthesia—Pamidronate—osteoporosis	0.00037	0.00214	CcSEcCtD
Vinblastine—Diarrhoea—Alendronate—osteoporosis	0.000369	0.00214	CcSEcCtD
Vinblastine—Asthenia—Calcitriol—osteoporosis	0.000369	0.00214	CcSEcCtD
Vinblastine—Thrombocytopenia—Zoledronate—osteoporosis	0.000368	0.00213	CcSEcCtD
Vinblastine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000366	0.00212	CcSEcCtD
Vinblastine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000363	0.0021	CcSEcCtD
Vinblastine—Diarrhoea—Raloxifene—osteoporosis	0.000363	0.0021	CcSEcCtD
Vinblastine—Dizziness—Estropipate—osteoporosis	0.000362	0.0021	CcSEcCtD
Vinblastine—Alopecia—Estradiol—osteoporosis	0.00036	0.00209	CcSEcCtD
Vinblastine—Diarrhoea—Ibandronate—osteoporosis	0.00036	0.00208	CcSEcCtD
Vinblastine—Anorexia—Zoledronate—osteoporosis	0.000358	0.00207	CcSEcCtD
Vinblastine—Decreased appetite—Pamidronate—osteoporosis	0.000358	0.00207	CcSEcCtD
Vinblastine—Dizziness—Alendronate—osteoporosis	0.000357	0.00207	CcSEcCtD
Vinblastine—Gastrointestinal pain—Risedronate—osteoporosis	0.000354	0.00205	CcSEcCtD
Vinblastine—Constipation—Pamidronate—osteoporosis	0.000352	0.00204	CcSEcCtD
Vinblastine—Pain—Pamidronate—osteoporosis	0.000352	0.00204	CcSEcCtD
Vinblastine—Diarrhoea—Calcitriol—osteoporosis	0.000352	0.00204	CcSEcCtD
Vinblastine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000351	0.00203	CcSEcCtD
Vinblastine—Dizziness—Raloxifene—osteoporosis	0.000351	0.00203	CcSEcCtD
Vinblastine—Vomiting—Estropipate—osteoporosis	0.000348	0.00202	CcSEcCtD
Vinblastine—Dizziness—Ibandronate—osteoporosis	0.000347	0.00201	CcSEcCtD
Vinblastine—Anorexia—Conjugated Estrogens—osteoporosis	0.000345	0.002	CcSEcCtD
Vinblastine—Headache—Estropipate—osteoporosis	0.000343	0.00199	CcSEcCtD
Vinblastine—Vomiting—Alendronate—osteoporosis	0.000343	0.00199	CcSEcCtD
Vinblastine—Abdominal pain—Risedronate—osteoporosis	0.000342	0.00198	CcSEcCtD
Vinblastine—Feeling abnormal—Pamidronate—osteoporosis	0.000339	0.00196	CcSEcCtD
Vinblastine—Headache—Alendronate—osteoporosis	0.000338	0.00196	CcSEcCtD
Vinblastine—Paraesthesia—Zoledronate—osteoporosis	0.000338	0.00195	CcSEcCtD
Vinblastine—Vomiting—Raloxifene—osteoporosis	0.000337	0.00195	CcSEcCtD
Vinblastine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000337	0.00195	CcSEcCtD
Vinblastine—Vomiting—Ibandronate—osteoporosis	0.000334	0.00193	CcSEcCtD
Vinblastine—Headache—Raloxifene—osteoporosis	0.000332	0.00192	CcSEcCtD
Vinblastine—Ill-defined disorder—Estradiol—osteoporosis	0.000329	0.00191	CcSEcCtD
Vinblastine—Headache—Ibandronate—osteoporosis	0.000329	0.0019	CcSEcCtD
Vinblastine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000327	0.00189	CcSEcCtD
Vinblastine—Vomiting—Calcitriol—osteoporosis	0.000327	0.00189	CcSEcCtD
Vinblastine—Decreased appetite—Zoledronate—osteoporosis	0.000327	0.00189	CcSEcCtD
Vinblastine—Nausea—Estropipate—osteoporosis	0.000325	0.00188	CcSEcCtD
Vinblastine—Abdominal pain—Pamidronate—osteoporosis	0.000325	0.00188	CcSEcCtD
Vinblastine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000325	0.00188	CcSEcCtD
Vinblastine—Headache—Calcitriol—osteoporosis	0.000322	0.00186	CcSEcCtD
Vinblastine—Constipation—Zoledronate—osteoporosis	0.000322	0.00186	CcSEcCtD
Vinblastine—Pain—Zoledronate—osteoporosis	0.000322	0.00186	CcSEcCtD
Vinblastine—Nausea—Alendronate—osteoporosis	0.000321	0.00186	CcSEcCtD
Vinblastine—Malaise—Estradiol—osteoporosis	0.00032	0.00185	CcSEcCtD
Vinblastine—Hypersensitivity—Risedronate—osteoporosis	0.000319	0.00185	CcSEcCtD
Vinblastine—Vertigo—Estradiol—osteoporosis	0.000319	0.00185	CcSEcCtD
Vinblastine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000319	0.00184	CcSEcCtD
Vinblastine—Nausea—Raloxifene—osteoporosis	0.000315	0.00182	CcSEcCtD
Vinblastine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000315	0.00182	CcSEcCtD
Vinblastine—Nausea—Ibandronate—osteoporosis	0.000312	0.00181	CcSEcCtD
Vinblastine—Asthenia—Risedronate—osteoporosis	0.000311	0.0018	CcSEcCtD
Vinblastine—Feeling abnormal—Zoledronate—osteoporosis	0.00031	0.00179	CcSEcCtD
Vinblastine—Constipation—Conjugated Estrogens—osteoporosis	0.00031	0.00179	CcSEcCtD
Vinblastine—Pain—Conjugated Estrogens—osteoporosis	0.00031	0.00179	CcSEcCtD
Vinblastine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000307	0.00178	CcSEcCtD
Vinblastine—Hypertension—Estradiol—osteoporosis	0.000307	0.00177	CcSEcCtD
Vinblastine—Nausea—Calcitriol—osteoporosis	0.000306	0.00177	CcSEcCtD
Vinblastine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000304	0.00176	CcSEcCtD
Vinblastine—Hypersensitivity—Pamidronate—osteoporosis	0.000303	0.00176	CcSEcCtD
Vinblastine—Discomfort—Estradiol—osteoporosis	0.000299	0.00173	CcSEcCtD
Vinblastine—Abdominal pain—Zoledronate—osteoporosis	0.000297	0.00172	CcSEcCtD
Vinblastine—Diarrhoea—Risedronate—osteoporosis	0.000296	0.00171	CcSEcCtD
Vinblastine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000296	0.00171	CcSEcCtD
Vinblastine—Asthenia—Pamidronate—osteoporosis	0.000295	0.00171	CcSEcCtD
Vinblastine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000294	0.0017	CcSEcCtD
Vinblastine—Dizziness—Risedronate—osteoporosis	0.000286	0.00166	CcSEcCtD
Vinblastine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000286	0.00166	CcSEcCtD
Vinblastine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000282	0.00163	CcSEcCtD
Vinblastine—Diarrhoea—Pamidronate—osteoporosis	0.000282	0.00163	CcSEcCtD
Vinblastine—Headache—Ethinyl Estradiol—osteoporosis	0.000278	0.00161	CcSEcCtD
Vinblastine—Hypersensitivity—Zoledronate—osteoporosis	0.000277	0.0016	CcSEcCtD
Vinblastine—Vomiting—Risedronate—osteoporosis	0.000275	0.00159	CcSEcCtD
Vinblastine—Dizziness—Pamidronate—osteoporosis	0.000272	0.00158	CcSEcCtD
Vinblastine—Headache—Risedronate—osteoporosis	0.000271	0.00157	CcSEcCtD
Vinblastine—Asthenia—Zoledronate—osteoporosis	0.00027	0.00156	CcSEcCtD
Vinblastine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000267	0.00154	CcSEcCtD
Vinblastine—Nausea—Ethinyl Estradiol—osteoporosis	0.000264	0.00153	CcSEcCtD
Vinblastine—Vomiting—Pamidronate—osteoporosis	0.000262	0.00151	CcSEcCtD
Vinblastine—Paraesthesia—Estradiol—osteoporosis	0.00026	0.00151	CcSEcCtD
Vinblastine—Asthenia—Conjugated Estrogens—osteoporosis	0.00026	0.0015	CcSEcCtD
Vinblastine—Headache—Pamidronate—osteoporosis	0.000258	0.00149	CcSEcCtD
Vinblastine—Diarrhoea—Zoledronate—osteoporosis	0.000257	0.00149	CcSEcCtD
Vinblastine—Nausea—Risedronate—osteoporosis	0.000257	0.00149	CcSEcCtD
Vinblastine—Decreased appetite—Estradiol—osteoporosis	0.000252	0.00146	CcSEcCtD
Vinblastine—Dizziness—Zoledronate—osteoporosis	0.000249	0.00144	CcSEcCtD
Vinblastine—Constipation—Estradiol—osteoporosis	0.000248	0.00143	CcSEcCtD
Vinblastine—Pain—Estradiol—osteoporosis	0.000248	0.00143	CcSEcCtD
Vinblastine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000248	0.00143	CcSEcCtD
Vinblastine—Nausea—Pamidronate—osteoporosis	0.000245	0.00142	CcSEcCtD
Vinblastine—Dizziness—Conjugated Estrogens—osteoporosis	0.000239	0.00139	CcSEcCtD
Vinblastine—Vomiting—Zoledronate—osteoporosis	0.000239	0.00138	CcSEcCtD
Vinblastine—Feeling abnormal—Estradiol—osteoporosis	0.000239	0.00138	CcSEcCtD
Vinblastine—Gastrointestinal pain—Estradiol—osteoporosis	0.000237	0.00137	CcSEcCtD
Vinblastine—Headache—Zoledronate—osteoporosis	0.000236	0.00136	CcSEcCtD
Vinblastine—Vomiting—Conjugated Estrogens—osteoporosis	0.00023	0.00133	CcSEcCtD
Vinblastine—Abdominal pain—Estradiol—osteoporosis	0.000229	0.00133	CcSEcCtD
Vinblastine—Headache—Conjugated Estrogens—osteoporosis	0.000227	0.00131	CcSEcCtD
Vinblastine—Nausea—Zoledronate—osteoporosis	0.000223	0.00129	CcSEcCtD
Vinblastine—Nausea—Conjugated Estrogens—osteoporosis	0.000215	0.00124	CcSEcCtD
Vinblastine—Hypersensitivity—Estradiol—osteoporosis	0.000213	0.00124	CcSEcCtD
Vinblastine—Asthenia—Estradiol—osteoporosis	0.000208	0.0012	CcSEcCtD
Vinblastine—Diarrhoea—Estradiol—osteoporosis	0.000198	0.00115	CcSEcCtD
Vinblastine—Dizziness—Estradiol—osteoporosis	0.000192	0.00111	CcSEcCtD
Vinblastine—ABCB1—uterus—osteoporosis	0.000186	0.00749	CbGeAlD
Vinblastine—Vomiting—Estradiol—osteoporosis	0.000184	0.00107	CcSEcCtD
Vinblastine—Headache—Estradiol—osteoporosis	0.000182	0.00105	CcSEcCtD
Vinblastine—Nausea—Estradiol—osteoporosis	0.000172	0.000996	CcSEcCtD
Vinblastine—ABCB1—bone marrow—osteoporosis	0.000158	0.00636	CbGeAlD
Vinblastine—TUBB6—Metabolism of proteins—POMC—osteoporosis	2.75e-05	0.000122	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—IL6—osteoporosis	2.74e-05	0.000122	CbGpPWpGaD
Vinblastine—JUN—Immune System—RAP1A—osteoporosis	2.74e-05	0.000121	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MGLL—osteoporosis	2.72e-05	0.000121	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTSK—osteoporosis	2.72e-05	0.00012	CbGpPWpGaD
Vinblastine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.7e-05	0.00012	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MGLL—osteoporosis	2.69e-05	0.000119	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFATC1—osteoporosis	2.67e-05	0.000118	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LRP5—osteoporosis	2.66e-05	0.000118	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—POMC—osteoporosis	2.65e-05	0.000118	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—MYC—osteoporosis	2.65e-05	0.000118	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—IGF1—osteoporosis	2.64e-05	0.000117	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—IGF1—osteoporosis	2.64e-05	0.000117	CbGpPWpGaD
Vinblastine—ABCC2—NRF2 pathway—TGFB1—osteoporosis	2.64e-05	0.000117	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TNF—osteoporosis	2.64e-05	0.000117	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—LEP—osteoporosis	2.62e-05	0.000116	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.61e-05	0.000116	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—TPI1—osteoporosis	2.59e-05	0.000115	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—POMC—osteoporosis	2.57e-05	0.000114	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.56e-05	0.000113	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—IGF1—osteoporosis	2.55e-05	0.000113	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.55e-05	0.000113	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LRP6—osteoporosis	2.54e-05	0.000113	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.54e-05	0.000113	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—POMC—osteoporosis	2.51e-05	0.000111	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.5e-05	0.000111	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ACP5—osteoporosis	2.5e-05	0.000111	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AGER—osteoporosis	2.49e-05	0.00011	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—ADCY5—osteoporosis	2.48e-05	0.00011	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	2.48e-05	0.00011	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—IGF1—osteoporosis	2.47e-05	0.00011	CbGpPWpGaD
Vinblastine—JUN—Toll-Like Receptors Cascades—IL6—osteoporosis	2.45e-05	0.000109	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—P4HB—osteoporosis	2.43e-05	0.000108	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—IGF1—osteoporosis	2.42e-05	0.000107	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CA2—osteoporosis	2.4e-05	0.000107	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—OXCT1—osteoporosis	2.4e-05	0.000107	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—LEP—osteoporosis	2.4e-05	0.000106	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GAPDH—osteoporosis	2.39e-05	0.000106	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.38e-05	0.000106	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—MYC—osteoporosis	2.37e-05	0.000105	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MGLL—osteoporosis	2.34e-05	0.000104	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—RAP1A—osteoporosis	2.33e-05	0.000103	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TPI1—osteoporosis	2.32e-05	0.000103	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—IDH2—osteoporosis	2.29e-05	0.000101	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	2.27e-05	0.000101	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL6—osteoporosis	2.26e-05	0.0001	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—POMC—osteoporosis	2.25e-05	0.0001	CbGpPWpGaD
Vinblastine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.19e-05	9.72e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—P4HB—osteoporosis	2.18e-05	9.69e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PSMA2—osteoporosis	2.18e-05	9.67e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PSMA5—osteoporosis	2.18e-05	9.67e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IRS2—osteoporosis	2.17e-05	9.63e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—IGF1—osteoporosis	2.17e-05	9.62e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP27A1—osteoporosis	2.15e-05	9.54e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TLN1—osteoporosis	2.15e-05	9.53e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—GAPDH—osteoporosis	2.14e-05	9.51e-05	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—MYC—osteoporosis	2.11e-05	9.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ACP5—osteoporosis	2.09e-05	9.28e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.07e-05	9.16e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—POMC—osteoporosis	2.06e-05	9.15e-05	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	2.04e-05	9.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NFATC1—osteoporosis	2.04e-05	9.03e-05	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2.03e-05	9e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.03e-05	9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—DKK1—osteoporosis	2.02e-05	8.96e-05	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.99e-05	8.85e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—IDH2—osteoporosis	1.99e-05	8.84e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—IGF1—osteoporosis	1.98e-05	8.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.97e-05	8.74e-05	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL6—osteoporosis	1.96e-05	8.71e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—WNT1—osteoporosis	1.95e-05	8.63e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—TPI1—osteoporosis	1.94e-05	8.63e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.94e-05	8.59e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.93e-05	8.56e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.91e-05	8.47e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IRS1—osteoporosis	1.9e-05	8.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—osteoporosis	1.9e-05	8.41e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGA—osteoporosis	1.89e-05	8.4e-05	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MYC—osteoporosis	1.89e-05	8.37e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ENO1—osteoporosis	1.88e-05	8.34e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP27A1—osteoporosis	1.87e-05	8.31e-05	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—MYC—osteoporosis	1.87e-05	8.28e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PSMA2—osteoporosis	1.85e-05	8.22e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PSMA5—osteoporosis	1.85e-05	8.22e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—P4HB—osteoporosis	1.85e-05	8.21e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KL—osteoporosis	1.85e-05	8.19e-05	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—IL6—osteoporosis	1.84e-05	8.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—P4HB—osteoporosis	1.83e-05	8.11e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ACP5—osteoporosis	1.82e-05	8.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTH—osteoporosis	1.8e-05	7.99e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GAPDH—osteoporosis	1.79e-05	7.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PKM—osteoporosis	1.78e-05	7.9e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—FDPS—osteoporosis	1.78e-05	7.9e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6R—osteoporosis	1.78e-05	7.9e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Biological oxidations—POMC—osteoporosis	1.78e-05	7.9e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RAP1A—osteoporosis	1.77e-05	7.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CNR2—osteoporosis	1.76e-05	7.79e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—MYC—osteoporosis	1.75e-05	7.76e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—RAP1A—osteoporosis	1.75e-05	7.75e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFATC1—osteoporosis	1.73e-05	7.66e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.72e-05	7.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—DKK1—osteoporosis	1.71e-05	7.6e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—TPI1—osteoporosis	1.69e-05	7.51e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PGLS—osteoporosis	1.69e-05	7.49e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPD2—osteoporosis	1.69e-05	7.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ENO1—osteoporosis	1.69e-05	7.49e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FDPS—osteoporosis	1.68e-05	7.45e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PKM—osteoporosis	1.68e-05	7.45e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.67e-05	7.41e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PSMA2—osteoporosis	1.66e-05	7.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PSMA5—osteoporosis	1.66e-05	7.38e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—WNT1—osteoporosis	1.65e-05	7.32e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGA—osteoporosis	1.61e-05	7.12e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	1.6e-05	7.1e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—P4HB—osteoporosis	1.59e-05	7.06e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPD2—osteoporosis	1.59e-05	7.06e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PGLS—osteoporosis	1.59e-05	7.06e-05	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MYC—osteoporosis	1.56e-05	6.94e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GAPDH—osteoporosis	1.56e-05	6.93e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CALCA—osteoporosis	1.55e-05	6.87e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PNP—osteoporosis	1.54e-05	6.85e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ATIC—osteoporosis	1.54e-05	6.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.52e-05	6.76e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—RAP1A—osteoporosis	1.52e-05	6.75e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CYP19A1—osteoporosis	1.5e-05	6.67e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTHLH—osteoporosis	1.49e-05	6.62e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BMP2—osteoporosis	1.49e-05	6.62e-05	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL6—osteoporosis	1.48e-05	6.58e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGB—osteoporosis	1.46e-05	6.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ATIC—osteoporosis	1.46e-05	6.46e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PNP—osteoporosis	1.46e-05	6.46e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AGER—osteoporosis	1.45e-05	6.44e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—ADCY5—osteoporosis	1.45e-05	6.41e-05	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MYC—osteoporosis	1.43e-05	6.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ENO1—osteoporosis	1.41e-05	6.27e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PSMA5—osteoporosis	1.41e-05	6.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PSMA2—osteoporosis	1.41e-05	6.26e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KL—osteoporosis	1.41e-05	6.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PSMA2—osteoporosis	1.39e-05	6.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PSMA5—osteoporosis	1.39e-05	6.18e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CALCA—osteoporosis	1.31e-05	5.83e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CA2—osteoporosis	1.31e-05	5.83e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—OXCT1—osteoporosis	1.31e-05	5.83e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MGLL—osteoporosis	1.28e-05	5.68e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IRS2—osteoporosis	1.26e-05	5.61e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CA2—osteoporosis	1.24e-05	5.49e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.24e-05	5.49e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ENO1—osteoporosis	1.23e-05	5.46e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ADCY5—osteoporosis	1.23e-05	5.45e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—GPX1—osteoporosis	1.22e-05	5.43e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PSMA5—osteoporosis	1.21e-05	5.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PSMA2—osteoporosis	1.21e-05	5.38e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MGLL—osteoporosis	1.21e-05	5.35e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KL—osteoporosis	1.19e-05	5.29e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.16e-05	5.16e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—MTHFR—osteoporosis	1.13e-05	5.01e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CYP19A1—osteoporosis	1.13e-05	5.01e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IRS1—osteoporosis	1.1e-05	4.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ADCY5—osteoporosis	1.1e-05	4.89e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PKM—osteoporosis	1.1e-05	4.87e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FDPS—osteoporosis	1.1e-05	4.87e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—IDH2—osteoporosis	1.09e-05	4.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PGLS—osteoporosis	1.04e-05	4.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPD2—osteoporosis	1.04e-05	4.62e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6R—osteoporosis	1.04e-05	4.6e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—IDH2—osteoporosis	1.03e-05	4.55e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP27A1—osteoporosis	1.02e-05	4.54e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTHFR—osteoporosis	1.01e-05	4.5e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1e-05	4.45e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1e-05	4.44e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ACP5—osteoporosis	9.95e-06	4.42e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP19A1—osteoporosis	9.84e-06	4.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IRS2—osteoporosis	9.64e-06	4.28e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP27A1—osteoporosis	9.64e-06	4.28e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ATIC—osteoporosis	9.52e-06	4.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PNP—osteoporosis	9.52e-06	4.22e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ACP5—osteoporosis	9.38e-06	4.16e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.38e-06	4.16e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	9.35e-06	4.15e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ADCY5—osteoporosis	9.35e-06	4.15e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—TPI1—osteoporosis	9.25e-06	4.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ADCY5—osteoporosis	9.23e-06	4.09e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GPX1—osteoporosis	9.2e-06	4.08e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SPP1—osteoporosis	9.04e-06	4.01e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—POMC—osteoporosis	9.04e-06	4.01e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—TPI1—osteoporosis	8.72e-06	3.87e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—P4HB—osteoporosis	8.7e-06	3.86e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GAPDH—osteoporosis	8.54e-06	3.79e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—osteoporosis	8.49e-06	3.77e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IRS1—osteoporosis	8.42e-06	3.73e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—RAP1A—osteoporosis	8.32e-06	3.69e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—P4HB—osteoporosis	8.2e-06	3.64e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IRS2—osteoporosis	8.18e-06	3.63e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CA2—osteoporosis	8.09e-06	3.59e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—OXCT1—osteoporosis	8.09e-06	3.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GAPDH—osteoporosis	8.05e-06	3.57e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ADCY5—osteoporosis	8.04e-06	3.57e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GPX1—osteoporosis	8.01e-06	3.55e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LEP—osteoporosis	8e-06	3.55e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—osteoporosis	7.93e-06	3.52e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6R—osteoporosis	7.91e-06	3.51e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1B—osteoporosis	7.89e-06	3.5e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MGLL—osteoporosis	7.88e-06	3.5e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—RAP1A—osteoporosis	7.84e-06	3.48e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—osteoporosis	7.64e-06	3.39e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—osteoporosis	7.39e-06	3.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IRS1—osteoporosis	7.14e-06	3.17e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—POMC—osteoporosis	6.88e-06	3.05e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—POMC—osteoporosis	6.79e-06	3.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ENO1—osteoporosis	6.72e-06	2.98e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6R—osteoporosis	6.71e-06	2.98e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—IDH2—osteoporosis	6.7e-06	2.97e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMA2—osteoporosis	6.62e-06	2.94e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMA5—osteoporosis	6.62e-06	2.94e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—osteoporosis	6.61e-06	2.93e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ENO1—osteoporosis	6.34e-06	2.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.3e-06	2.8e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMA5—osteoporosis	6.24e-06	2.77e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMA2—osteoporosis	6.24e-06	2.77e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACP5—osteoporosis	6.13e-06	2.72e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—POMC—osteoporosis	5.91e-06	2.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—TPI1—osteoporosis	5.7e-06	2.53e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP19A1—osteoporosis	5.37e-06	2.38e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—P4HB—osteoporosis	5.36e-06	2.38e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GAPDH—osteoporosis	5.26e-06	2.33e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—RAP1A—osteoporosis	5.12e-06	2.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.06e-06	2.25e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—osteoporosis	4.69e-06	2.08e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—osteoporosis	4.67e-06	2.07e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—osteoporosis	4.62e-06	2.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADCY5—osteoporosis	4.39e-06	1.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPX1—osteoporosis	4.38e-06	1.94e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ENO1—osteoporosis	4.14e-06	1.84e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.14e-06	1.84e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPX1—osteoporosis	4.12e-06	1.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMA2—osteoporosis	4.08e-06	1.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMA5—osteoporosis	4.08e-06	1.81e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—osteoporosis	4.04e-06	1.79e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—osteoporosis	3.97e-06	1.76e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—osteoporosis	3.96e-06	1.76e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—osteoporosis	3.81e-06	1.69e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—osteoporosis	3.52e-06	1.56e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.31e-06	1.47e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—POMC—osteoporosis	3.23e-06	1.43e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—POMC—osteoporosis	3.04e-06	1.35e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—osteoporosis	2.99e-06	1.33e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADCY5—osteoporosis	2.71e-06	1.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPX1—osteoporosis	2.7e-06	1.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—osteoporosis	2.49e-06	1.1e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—POMC—osteoporosis	1.99e-06	8.83e-06	CbGpPWpGaD
